Appointments
+(603) 5515 1966
General Line
+(603) 5515 1888
March 6, 2025
Breast cancer is one of the most prevalent forms of cancer affecting women globally. While early detection and treatment have significantly improved outcomes, metastatic breast cancer, or Stage IV breast cancer, presents unique challenges.
In this comprehensive guide, we will focus on the symptoms of metastatic breast cancer, particularly when it spreads to bones, end-stage symptoms, diagnosis, treatment, survival rates, and crucial red flag signs every woman should know.
Metastatic breast cancer (MBC) refers to cancer that has spread from the primary site in the breast to distant organs such as the bones, liver, lungs, or brain. Despite advancements in medical science, metastatic breast cancer remains incurable, though it is manageable with the right treatment plan.
| Incident | Survival Rate | Progression |
|---|---|---|
| Approximately 20-30% of women diagnosed with early-stage breast cancer eventually develop metastatic breast cancer. | While the metastatic breast cancer survival rate has improved over the years, it remains lower compared to early-stage breast cancer. On average, the five-year survival rate for women with MBC is about 29%, but this varies depending on the site of metastasis, overall health, and response to treatment. | MBC can develop years after the initial breast cancer diagnosis or as a recurrence. |
Recognising the symptoms of metastatic breast cancer can help in early intervention. Symptoms vary based on the location of metastasis.
In general, the common symptoms include:
The symptoms may vary based on where the cancer has grown and spread.
Red flag signs indicate that breast cancer may have progressed or metastasised. Women experiencing these symptoms should seek medical evaluation promptly:
In the final stages of metastatic breast cancer, symptoms can become more severe and widespread. These may include:
Palliative care is essential at this stage to alleviate pain and maintain the best possible quality of life.
Early and accurate diagnosis of metastatic breast cancer plays an important role in determining the extent of the disease, guiding treatment decisions, and managing symptoms to provide tailored therapies for patients.
Understanding Symptoms: Diagnosis often begins with evaluating symptoms reported by the patient. These may include persistent bone pain, breathing difficulties, unexplained weight loss, or neurological changes, depending on the site of metastasis.
Clinical Examination: A thorough physical examination is performed to detect any abnormalities, such as swollen lymph nodes, pain in specific areas, or signs of organ dysfunction.
Imaging Tests: Imaging plays a vital role in identifying the spread of cancer. Common imaging methods used for this purpose include:
Biopsy: A biopsy involves taking a sample of tissue from the suspected metastatic site for examination under a microscope. This confirms the presence of cancer cells and determines whether they originated from the breast. The biopsy also helps in analysing the cancer’s hormone receptor (HR) and HER2 status, which are crucial for treatment planning.
Blood Tests: Blood tests help assess overall health and identify abnormalities that may indicate metastasis. Some blood tests that are commonly used are:
Genetic and Molecular Testing: Molecular profiling can identify genetic mutations, such as BRCA1, BRCA2, or PIK3CA, which may guide targeted treatment strategies. PD-L1 or MSI-H testing may be done to determine eligibility for immunotherapy.
Lumbar Puncture or Brain Imaging (if needed): In cases where neurological symptoms suggest brain or spinal cord involvement, a lumbar puncture (spinal tap) or specialized brain imaging may be conducted.
Metastatic breast cancer is treatable but remains incurable., with the main goals being to control the disease, relieve symptoms, improve quality of life, and extend survival. Treatment plans are personalised based on factors such as the location of metastasis, hormone receptor status, HER2 status, genetic mutations, and overall health. Here are some of the key treatment approaches commonly adopted:
Hormone receptor-positive cancers can be treated effectively with hormone therapy like Aromatase Inhibitors and Selective Oestrogen Receptor Modulators. These medications block the growth signals of cancer cells that rely on oestrogen or progesterone for growth. Combining hormone therapy with targeted therapies, such as CDK4/6 inhibitors, can prevent cancer cells from dividing and manage the cancer effectively.
Targeted therapies focus on specific molecular characteristics of the cancer, such as HER2 or other genetic mutations.
Alpelisib (Piqray): A PI3K inhibitor, often combined with fulvestrant for HR+/HER2-negative cancers.
PARP Inhibitors (e.g., Olaparib, Talazoparib): These target DNA repair pathways in BRCA-mutated cancers.
Enhertu (Trastuzumab deruxtecan): A newer therapy for HER2-low cancers, offering significant survival benefits.
Chemotherapy continues to be a fundamental treatment for metastatic cancer, especially for aggressive or hormone receptor-negative cancers. This treatment is administered in cycles and functions by targeting and destroying rapidly dividing cancer cells. Some commonly used drugs in chemotherapy include Paclitaxel, Doxorubicin, Capecitabine, and Eribulin. Chemotherapy is typically utilized when other treatment options have proven to be ineffective, or in cases of triple-negative cancer (TNBC).
Immunotherapy plays a crucial role in enhancing the immune system’s ability to identify and eliminate cancer cells. In the case of Triple-Negative Cancer (TNBC), two prominent immune checkpoint inhibitors, Atezolizumab and Pembrolizumab, are frequently utilised in conjunction with chemotherapy for patients with PD-L1-positive TNBC.
Radiation therapy is commonly used to control localised symptoms, such as pain or fractures caused by bone metastasis or complications in other organs. Stereotactic radiosurgery (SRS) is particularly effective for brain metastases.
Surgery is not typically used for metastatic breast cancer but may be considered in specific situations, such as:
Patients with bone metastases can benefit from treatments like bisphosphonates and RANK Ligand Inhibitors, which help prevent fractures, reduce pain, and strengthen bones by slowing down bone damage and preventing breakdown. These treatments improve the quality of life for patients with bone metastases.
Palliative care focuses on improving the quality of life for patients with metastatic breast cancer by managing symptoms, addressing emotional and psychological needs, and providing holistic support. It works in conjunction with active cancer treatments and is tailored to individual needs. Common supportive treatments include:
Metastatic cancer is hard to prevent, but catching it early, effective treatment and healthy living can lower the risk of progression or recurrence.
Regular mammograms and exams can catch cancer early, which lowers the risk of it advancing. Patients with early-stage cancer should stick to their follow-up schedules for monitoring. Testing for gene mutations can help guide preventive measures like increased monitoring or surgery.
Completing recommended treatments like surgery, chemotherapy, radiation, and hormone therapy is crucial for eradicating leftover cancer cells. Sticking to hormone therapy for 5-10 years can reduce the risk of cancer returning, while HER2-targeted therapies like trastuzumab can lower the chance of cancer spreading.
Eating a diet full of fruits, vegetables, whole grains, and lean proteins and exercising for at least 150 minutes per week can lower cancer risk and improve overall health. It is important to maintain a healthy weight to reduce the risk of cancer recurrence and metastasis.
Properly managing conditions like diabetes, hypertension, and osteoporosis can improve overall health and resilience during cancer treatment.
Limit alcohol intake to reduce the risk of breast cancer recurrence and metastasis. Avoid smoking, as it is linked to poorer outcomes in breast cancer patients.
A metastatic cancer diagnosis can be daunting, but women can still lead fulfilling lives with the right support, healthcare team, and a positive mindset.
Here are some tips that you may find useful:
Metastatic breast cancer is a challenging diagnosis, but advances in medical science have transformed its management. By understanding the symptoms, red flag signs, treatment options, and survival statistics, women can take control of their healthcare journey and make informed decisions.
Knowledge is power. If you or someone you know is facing metastatic breast cancer, share this guide to spread awareness and foster a community of support and understanding. With continued research and advocacy, the outlook for metastatic breast cancer patients will only improve.
The first signs of metastatic breast cancer often include persistent bone pain, unexplained fatigue, shortness of breath, or other symptoms specific to the area of metastasis, such as swelling or neurological changes.
The most common places for breast cancer to metastasize are the bones, followed by the lungs, liver, and brain.
Metastatic breast cancer is not curable, but treatments can manage the disease, prolong survival, and improve quality of life.
Sources
Spread the love, follow us on our social media channels